New findings raise HRT risks
Sales of supplements for menopause symptoms are likely to surge in coming months, after a major UK study finds that combination hormone replacement therapy (HRT) could double the risk of breast cancer.
Sales of supplements for menopause symptoms are likely to surge in coming months, after a major UK study finds that combination hormone replacement therapy (HRT) could double the risk of breast cancer.
Products containing the herb Chelidonium majus should include a warning label to consumers, Australia's Complementary Medicines Evaluation Committee has advised.
Newly-formed Acatris is planning a major assault on the UK market and has predicted that Britain will be among the top three growth markets for its health ingredients.